688131 皓元医药
2024/03 - 三个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额28,325(63,606)(240,233)57,835116,789
投资活动产生之现金流量净额(119,512)(328,511)(713,002)(305,839)(74,161)
筹资活动产生之现金流量净额59,979409,209360,3241,007,29450,277
汇率变动对现金及现金等价物的影响(426)3,11114,415(7,242)(9,290)
现金及现金等价物净增加/(减少)(31,634)20,202(578,496)752,04783,616
期初现金及现金等价物余额475,466455,2641,033,760281,713198,097
期末现金及现金等价物余额443,832475,466455,2641,033,760281,713